Javascript must be enabled to continue!
Modified Jiaoqi powder ameliorates ulcerative colitis through gut microbiota-tryptophan metabolism-AhR signaling modulating-ILC2/ILC3 balance
View through CrossRef
Background
Ulcerative colitis (UC) occurs as a result of the interaction among intestinal microbiota, the intestinal barrier, and the immune system. The current treatment options have their limitations and come with side effects, thus there is an urgent need to develop new drug candidates for the treatment of UC. Modified Jiaoqi powder (MJQP) is a Traditional Chinese Medicine formulation improved from an empirical prescription prescribed by Tietao Deng, a celebrated master of Traditional Chinese Medicine. Although MJQP is a viable alternative medication for treating UC, the underlying mechanism is unclear yet.
Methods
Eight groups were designed: control, model, mesalazine group (400 mg/kg), MJQP low-, medium-, and high-dose (2.5, 5, 10 g/kg), AhR antagonist CH223191 (10 mg/kg) combined administration with MJQP (5 g/kg), and CH223191 group (10 mg/kg). The efficacy of MJQP was evaluated using the disease activity index (DAI), colonic length, and pathological alterations. RT-PCR, western blotting, alcian blue staining, immunofluorescence and transmission electron microscopy were used to detect tight junction proteins. The proportion and function of ILC2 and ILC3 were detected by flow cytometry and ELISA, and AhR signaling was examined by western blotting and RT-PCR. 16S rDNA sequencing and targeted tryptophan metabolite detection were used to detect the intestinal microflora and tryptophan metabolites.
Results
MJQP substantially restored body weight and colonic length in UC, and reduced DAI and colonic pathological alterations, while MJQP restored tight junctions of the colon to repair the intestinal barrier. Moreover, MJQP increased the levels of IL-22 and the proportion of IL-22
+
ILC3, while decreasing the proportion of IL-13
+
ILC2 and the generation of IL-13. Furthermore, MJQP up-regulated AhR and CYP1A1 expression and down-regulated the expression of ST2. However, these effects were hardly observed when MJQP was administered in combination with an AhR antagonist. Most strikingly, MJQP restored the abundance of
Lachnospiraceae, Lactobacillus
and
Clostridium
, and increased the gut microbiota derived tryptophan metabolites Indole-3-acetic acid (IAA) and Indole-3-propionic acid (IPA), which serve as endogenous AhR ligands to enhance AhR signaling.
Conclusion
MJQP repaired the damaged intestinal barrier to facilitate the resolution of chronic colitis by modulating AhR-mediated ILC2/ILC3 balance through gut microbiota-related tryptophan metabolism.
Frontiers Media SA
Title: Modified Jiaoqi powder ameliorates ulcerative colitis through gut microbiota-tryptophan metabolism-AhR signaling modulating-ILC2/ILC3 balance
Description:
Background
Ulcerative colitis (UC) occurs as a result of the interaction among intestinal microbiota, the intestinal barrier, and the immune system.
The current treatment options have their limitations and come with side effects, thus there is an urgent need to develop new drug candidates for the treatment of UC.
Modified Jiaoqi powder (MJQP) is a Traditional Chinese Medicine formulation improved from an empirical prescription prescribed by Tietao Deng, a celebrated master of Traditional Chinese Medicine.
Although MJQP is a viable alternative medication for treating UC, the underlying mechanism is unclear yet.
Methods
Eight groups were designed: control, model, mesalazine group (400 mg/kg), MJQP low-, medium-, and high-dose (2.
5, 5, 10 g/kg), AhR antagonist CH223191 (10 mg/kg) combined administration with MJQP (5 g/kg), and CH223191 group (10 mg/kg).
The efficacy of MJQP was evaluated using the disease activity index (DAI), colonic length, and pathological alterations.
RT-PCR, western blotting, alcian blue staining, immunofluorescence and transmission electron microscopy were used to detect tight junction proteins.
The proportion and function of ILC2 and ILC3 were detected by flow cytometry and ELISA, and AhR signaling was examined by western blotting and RT-PCR.
16S rDNA sequencing and targeted tryptophan metabolite detection were used to detect the intestinal microflora and tryptophan metabolites.
Results
MJQP substantially restored body weight and colonic length in UC, and reduced DAI and colonic pathological alterations, while MJQP restored tight junctions of the colon to repair the intestinal barrier.
Moreover, MJQP increased the levels of IL-22 and the proportion of IL-22
+
ILC3, while decreasing the proportion of IL-13
+
ILC2 and the generation of IL-13.
Furthermore, MJQP up-regulated AhR and CYP1A1 expression and down-regulated the expression of ST2.
However, these effects were hardly observed when MJQP was administered in combination with an AhR antagonist.
Most strikingly, MJQP restored the abundance of
Lachnospiraceae, Lactobacillus
and
Clostridium
, and increased the gut microbiota derived tryptophan metabolites Indole-3-acetic acid (IAA) and Indole-3-propionic acid (IPA), which serve as endogenous AhR ligands to enhance AhR signaling.
Conclusion
MJQP repaired the damaged intestinal barrier to facilitate the resolution of chronic colitis by modulating AhR-mediated ILC2/ILC3 balance through gut microbiota-related tryptophan metabolism.
Related Results
Adaptation of intestinal ILC3 behavior and function in response to environmental signals
Adaptation of intestinal ILC3 behavior and function in response to environmental signals
Adaptation des ILC3 intestinales en réponse aux signaux environnementaux
Les muqueuses, comme l'intestin, constituent le lieu privilégié de contact entre notre orga...
IMPACT OF GUT MICROBIOTA ON POSTOPERATIVE RECOVERY AND WOUND HEALING
IMPACT OF GUT MICROBIOTA ON POSTOPERATIVE RECOVERY AND WOUND HEALING
The gut microbiota, made up of trillions of microorganisms that inhabit the gastrointestinal tract, plays a fundamental role in human health, influencing immunological and metaboli...
FOXO1 pathway activation by VISTA immune checkpoint restrains pulmonary ILC2 functions
FOXO1 pathway activation by VISTA immune checkpoint restrains pulmonary ILC2 functions
Group 2 innate lymphoid cells (ILC2s) play a pivotal role in the development of airway hyperreactivity (AHR). However, the regulatory mechanisms governing ILC2 function remain inad...
VISTA regulates lung ILC2 metabolism and effector function through FOXO1 2223
VISTA regulates lung ILC2 metabolism and effector function through FOXO1 2223
Abstract Description
Growing evidence highlights the pivotal role of group 2 innate lymphoid cells (ILC2s) in the devel...
Tissue microenvironment induces tissue specificity of ILC2
Tissue microenvironment induces tissue specificity of ILC2
AbstractType 2 innate lymphoid cells were found to be members of the innate immune cell family, which is involved in innate and adaptive immunity to resist the invasion of foreign ...
Contribution of circulating host and microbial tryptophan metabolites towards Ah receptor activation
Contribution of circulating host and microbial tryptophan metabolites towards Ah receptor activation
AbstractThe aryl hydrocarbon receptor (AHR) is a ligand activated transcription factor that plays an integral role in homeostatic maintenance by regulating cellular functions such ...
Régulation métabolique de la plasticité des ILC2 au cours de l'infection par Mycobacterium tuberculosis
Régulation métabolique de la plasticité des ILC2 au cours de l'infection par Mycobacterium tuberculosis
Les muqueuses hébergent des cellules immunitaires résidentes qui jouent un double rôle : elles contribuent au maintien de l'intégrité tissulaire et à la protection du tissu lors d'...
Targeting CD48 Ameliorates ILC2-mediated Airway Hyperreactivity by Disrupting the PKCβ Pathway
Targeting CD48 Ameliorates ILC2-mediated Airway Hyperreactivity by Disrupting the PKCβ Pathway
Abstract
CD48 is a cell surface protein belonging to the signaling lymphocyte activation molecule family and is known to regulate immune cell function. Although a...

